Last updated at 17 Jul 2024 01:35 PM
Director
DIN: 02847440
Nishant Goel is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at STATUS PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02847440.Nishant Goel has previously been associated with 1 company in roles such as Director.Nishant Goel is currently involved in 2 different roles. Their most recent position is with EKANA HEALTH PRODUCTS LLP as a Designated Partner. The first company Nishant Goel was appointed to as a director was STATUS PHARMACEUTICALS PRIVATE LIMITED. Nishant Goel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Nishant Goel is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at STATUS PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02847440.Nishant Goel has previously been associated with 1 company in roles such as Director.Nishant Goel is currently involved in 2 different roles. Their most recent position is with EKANA HEALTH PRODUCTS LLP as a Designated Partner. The first company Nishant Goel was appointed to as a director was STATUS PHARMACEUTICALS PRIVATE LIMITED. Nishant Goel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (1)
3y 2m 1y 7m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
STATUS PHARMACEUTICALS PRIVATE LIMITED | Director | 31-Mar-2010 |
CROFORD HEALTHCARE PRIVATE LIMITED | Director | 27-Jul-2011 |